Browsing by Author Paramo, J.A. (José Antonio)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 60 to 79 of 140 < previous   next >
Issue DateTitleTypeAuthor(s)
1985Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulationArticuloColucci, M. (M.); Paramo, J.A. (José Antonio); Collen, D. (D.)
2009Hemorragia, hemostasia y trombosis en cirugíaArticuloParamo, J.A. (José Antonio)
1993Hemostasis in advanced liver diseaseArticuloParamo, J.A. (José Antonio); Rocha, E. (Eduardo)
1997Hemostatic markers in surgery: a different fibrinolytic activity may be of pathophysiological significance in orthopedic versus abdominal surgeryArticuloLopez, Y. (Yolanda); Paramo, J.A. (José Antonio); Valenti-Nin, J.R. (Juan Ramón); Pardo, F. (Fernando); Montes, R. (Ramón); Rocha, E. (Eduardo)
1993Heparinas de bajo peso molecularArticuloRocha, E. (Eduardo); Paramo, J.A. (José Antonio); Sarra, J. (J.)
2019High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patientsArticuloLorente, L. (Leonardo); Martin, M.M. (María M.); Ramos, L. (Luis); Argueso, M. (Mónica); Caceres, J.J. (Juan J.); Sole-Violan, J. (Jordi); Jimenez, A. (Alejandro); Borreguero-Leon, J.M. (Juan María); González-Rivero, A. (Agustín F.); Orbe, J. (Josune); Rodriguez, J.A. (José Antonio); Paramo, J.A. (José Antonio)
2007Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosisArticuloBlanco-Colio, L.M. (Luis M.); Martin-Ventura, J.L. (José Luis); Muñoz-Garcia, B. (Begoña); Orbe, J. (Josune); Paramo, J.A. (José Antonio); Michel, J.B. (Jean-Baptiste); Ortiz, A. (Alberto); Meilhac, O. (Olivier); Egido, J. (Jesús)
2023Immunothrombosis: molecular aspects and new therapeutic perspectivesArticuloMarcos-Jubilar, M. (María); Lecumberri, R. (Ramón); Paramo, J.A. (José Antonio)
1995Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver diseaseArticuloParamo, J.A. (José Antonio); Sangro, B. (Bruno); Prosper-Cardoso, F. (Felipe); Quiroga, J. (Jorge); Rifon, J. J. (Jose J.); Rocha, E. (Eduardo)
2008Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation testArticuloOrbe, J. (Josune); Zudaire, M. (Maite); Serrano, R. (Rosario); Coma-Canella, I. (Isabel); Martinez-de-Lizarrondo, S. (Sara); Rodriguez, J.A. (José Antonio); Paramo, J.A. (José Antonio)
2003Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjectsArticuloMartinez-Vila, E. (Eduardo); Paramo, J.A. (José Antonio); Beloqui, O. (Óscar); Orbe, J. (Josune); Irimia, P. (Pablo); Colina, I. (Inmaculada); Monreal, J.I. (José Ignacio); Benito-Boilos, A. (Alberto); Barba, J. (Joaquín); Zubieta, J.L. (José L.); Diez-Martinez, J. (Javier)
2005Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjectsArticuloParamo, J.A. (José Antonio); Beloqui, O. (Óscar); Colina, I. (Inmaculada); Diez-Martinez, J. (Javier); Orbe, J. (Josune)
1986Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived componentsArticuloColucci, M. (M.); Paramo, J.A. (José Antonio); Stassen, J.M. (J.M.); Collen, D. (D.)
1985Inherited haemorrhagic disease with abnormal prothrombin consumptionArticuloRocha, E. (Eduardo); Paramo, J.A. (José Antonio); Cuesta, B. (Braulia); Fernandez, J. (Javier)
1989Inhibidores de la coagulación en pacientes neoplásicosArticuloParamo, J.A. (José Antonio); Cuesta, B. (Braulia); Hernández, M. (M.); Fernandez, J. (Javier); Paloma, M.J. (María José); Rifon, J. J. (Jose J.); Rocha, E. (Eduardo)
1986Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivoArticuloColucci, M. (M.); Paramo, J.A. (José Antonio); Collen, D. (D.)
2018Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective studyArticuloFigueroa, R. (Rocío); Alfonso, A. (A.); Lopez-Picazo, J.M. (José M.); Gil-Bazo, I. (Ignacio); Garcia-Mouriz, A. (Alberto); Hermida, J. (José); Paramo, J.A. (José Antonio); Lecumberri, R. (Ramón)
2007Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patientsArticuloParamo, J.A. (José Antonio); Rodriguez, J.A. (José Antonio); Orbe, J. (Josune)
2002Involvement of leptin in the association between percentage of body fat and cardiovascular risk factorsArticuloGomez-Ambrosi, J. (Javier); Salvador, J. (Javier); Paramo, J.A. (José Antonio); Orbe, J. (Josune); Irala, J. (Jokin) de; Diez-Caballero, A. (Alberto); Gil, M.J. (María José); Álvarez-Cienfuegos, J. (Javier); Frühbeck, G. (Gema)
2022Lipocalin-2 and calprotectin potential prognosis biomarkers in peripheral arterial diseaseArticuloSáenz-de-Pipaon-Echarren, G. (Goren); Ravassa, S. (Susana); Larsen, K.L. (Katrine L.); Martínez-Aguilar, E. (Esther); Orbe, J. (Josune); Rodríguez-García, J.A. (José Antonio); Fernandez-Alonso, L. (Leopoldo); González-Miqueo, A. (Aránzazu); Martin-Ventura, J.L. (José Luis); Paramo, J.A. (José Antonio); Lindholt, J.S. (Jes S.); Roncal, C. (Carmen)